In this issue:
The quality of acute asthma care
Influence of longitudinal asthma phenotypes
Clusters in paediatric asthma or wheezing cohort
Mepolizumab or omalizumab treatment for ILC2s
MRI ventilation defect percent responses post-benralizumab
Bronchodilator responses after treatment
ARIs and asthma exacerbations
French early life wheeze profiles and asthma phenotypes
New model for ruling-in and ruling-out
Infiltrating mast cells and airway hyperresponsiveness
Please login below to download this issue (PDF)